31
SummaryWe studied experimental lagochilascariosis in male and female mice of four strains. The survival ratio and number of larvae recovered varied: B10.A and C57BL/6 mice had the highest number of larvae 90 days after infection and the lowest survival ratio at 345 days of infection. BALB/c mice had an intermediate survival ratio and number of larvae. A/J mice had the lowest number of larvae and the highest survival ratio. Our findings suggest that resistance to Lagochilascaris minor is not linked to the H-2 a region because both susceptible B10.A and resistant A/J mice express the H-2 a haplotype. However, the pattern of mortality and larvae recovered that we observed in C57BL/6 mice, which possess the same genetic background as B10.A, indicates that the background genotype does affect the outcome of lagochilascariosis in mice. This study demonstrates that the genetic background, but not H-2 a or sex, determine the outcome of lagochilascariosis in mice.
SummaryLagochilascaris minor is the causative agent of human lagochilascariosis, a disease that affects the neck region causing abscesses with eggs, adult parasites and L3/L4 larvae within purulent exudates. Nowadays, mice are considered intermediary hosts for the parasite. In previous study we observed that A/J mice experimentally infected with Lagochilascaris minor showed higher survival ratios than B10.A mice. Now, we denoted that A/J mice (resistant to experimental infection) produced higher levels of IgM, IgG and IgA against the crude extract (excepted for IgM) and secreted/excreted antigens of the parasite; on the other hand, B10.A mice (susceptible to experimental infection) produced higher levels of IgE in the later period of the experimental infection than A/J infected mice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.